Targeting histone deacetylases for cancer therapy: Trends and challenges

Dysregulation of histone deacetylases (HDACs) is closely related to tumor development and progression. As promising anticancer targets, HDACs have gained a great deal of research interests and two decades of effort has led to the approval of five HDAC inhibitors (HDACis). However, currently traditio...

Full description

Bibliographic Details

Main Authors:	Tao Liang, Fengli Wang, Reham M. Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2023-06-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	HDACs Oncogenesis Selective inhibitor Combination therapy Multitarget agent PROTAC
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383523000345
Tags:	Add Tag No Tags, Be the first to tag this record!